F-18 FDG PET/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer

Autor: P.P. Mainenti, Piernicola Pedicini, Daniela Capacchione, Giuseppe Guglielmi, Angela Venetucci, Giovanni Storto, Cesare Sirignano, Rosj Gallicchio, Anna Nardelli, Alessandra Pelagalli
Přispěvatelé: Gallicchio, Rosj, Nardelli, Anna, Venetucci, ANGELA ASSUNTA, Capacchione, Daniela, Pelagalli, Alessandra, Sirignano, Cesare, Mainenti, Pierpaolo, Pedicini, Piernicola, Guglielmi, Giuseppe, Storto, Giovanni
Rok vydání: 2017
Předmět:
Zdroj: European Journal of Radiology. 93:107-113
ISSN: 0720-048X
Popis: Objective We evaluated the prognostic impact of quantitative assessment by maximum standardized uptake value (SUVmax), metabolic tumour volume (MTV) and tumour lesion glycolysis (TLG) on [F-18] FDG PET/CT for patients with peritoneal carcinomatosis from epithelial ovarian cancer (EOC). Methods Thirty-one patients with EOC underwent PET/CT for an early restaging after cytoreductive surgery, having been diagnosed with carcinomatosis (before chemotherapy). The SUVmax, MTV (cm 3 ; 42% threshold) and TLG (g) were registered on residual peritoneal lesions. The patients were followed up 20 ± 12 months thereafter. The PET/CT results were compared to overall survival (OS). Results The Kaplan-Meier survival analysis for the SUVmax did not reveal significant differences in OS (p = 0.48). The MTV survival analysis showed a significant higher OS in patients presenting with a higher tumour burden than those with less tumour burden (p = 0.01; 26 vs. 14 months), whereas TLG exhibited a similar trend though not significant (p = 0.06). Apart from chemo-resistance, the higher the MTV, the better will be the response to chemotherapy. Conclusions Quantitative assessment by MTV rather than by SUVmax and TLG on PET/CT may be helpful for stratifying patients who present with peritoneal carcinomatosis from EOC, in order to implement the appropriate therapeutic regimen.
Databáze: OpenAIRE